Covid-19 roundup: NIH spotlights blood thinners in its next big trial; All it took was a pandemic to get JPM out of SF
After immune modulators and antibodies, blood thinners are the next class of drugs to be put through a Phase III trial organized under the NIH …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
